Table 1. Sample Characteristics.
| Characteristic | Participants, No. (%) (N = 20) |
|---|---|
| Age, mean (SD), y | 64.42 (8.49) |
| Sexa | |
| Female | 7 (36.8) |
| Male | 12 (63.2) |
| Racea | |
| White | 18 (94.7) |
| Black or African American | 1 (5.3) |
| Hispanic or Latino ethnicity | 1 (5.3) |
| Education | |
| Less than a high school degree | 0 |
| High school graduate | 3 (15.0) |
| Some college | 6 (30.0) |
| College graduate | 6 (30.0) |
| Postgraduate degree | 5 (25.0) |
| Time from trial consent to withdrawal from trial, mean (SD), d | 143 (95.3) |
| Cancer stage at enrollment in cancer clinical trialb | |
| II | 2 (11.8) |
| III | 4 (23.5) |
| IV | 11 (64.7) |
| Eastern Cooperative Oncology Group scale scorec | |
| 0 | 9 (45.0) |
| 1 | 11 (55.0) |
a
Data are missing for 1 participant.
b
Data are missing or not available for 3 participants.
c
On scale for assessment of disease progression, 0 indicates fully active, able to carry on all predisease performance without restriction, and 1 indicates restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (eg, light housework or office work).